Ex Parte Gardner et al - Page 3

                Appeal 2007-2956                                                                              
                Application 10/677,733                                                                        
                                               DISCUSSION                                                     
                      “[T]he Examiner bears the initial burden, on review of the prior art                    
                . . . , of presenting a prima facie case of unpatentability.  If that burden is               
                met, the burden of coming forward with evidence or argument shifts to the                     
                applicant.”  In re Oetiker, 977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444                         
                (Fed, Cir. 1992).  See also Hyatt v. Dudas, 492 F.3d 1365, 1369-70, 83                        
                USPQ2d 1373, 1375-76 (Fed. Cir. 2007).                                                        
                      The Examiner finds:                                                                     
                      1) Each of Edery, Takahaski, and Berkenstam describe PAS domain                         
                proteins with hydrophobic cores, satisfying the limitation of claim 1 of a                    
                PAS domain which is “predetermined, prefolded in its native state, and                        
                comprises a hydrophobic core that has no NMR-apparent a priori formed                         
                ligand cavity” (Answer 4-6).                                                                  
                      2) Edery, Takahaski, and Berkenstam teach identifying compounds                         
                which modulate the activity of the PAS domain protein (Answer 4-5).                           
                      3) Fesik teaches a method of identifying compounds which bind to                        
                proteins using NMR spectra (Answer 3).                                                        
                      The Examiner contends that it would have been obvious to have used                      
                Fesik’s NMR method to identify compounds which modulate the PAS                               
                domain proteins of Edery, Takahaski, and Berkenstam because Fesik teaches                     
                that its method is “amendable to automation for identification of modulator                   
                of protein activity” (Answer 5).                                                              
                      The Examiner’s case for prima facie obviousness is built on the                         
                presumption that the proteins described in each of Edery, Takahaski, and                      
                Berkenstam satisfy the claimed limitation of a PAS domain which is                            
                “predetermined, prefolded in its native state, and comprises a hydrophobic                    

                                                      3                                                       

Page:  Previous  1  2  3  4  5  6  7  8  9  Next

Last modified: September 9, 2013